JNJ Keeps Climbing. Should You Climb On?
This healthcare giant is on a serious run, but with the stock trading at a peak, investors must decide if …
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for JNJ skewed bullish (3 of 4 scored calls).
| المطلع | المنصب | التاريخ | النوع | القيمة |
|---|---|---|---|---|
| Taubert Jennifer L | EVP, WWC. … | Aug 17 '26 | Option Exercise | 1735050,0 |
| Taubert Jennifer L | EVP, WWC. … | Aug 17 '26 | Sale | 3950400,0 |
| Taubert Jennifer L | Officer | Aug 17 '26 | Proposed Sale | 3950418,0 |
| Duato Joaquin | CEO and … | Aug 13 '26 | Option Exercise | 14261070,0 |
| Duato Joaquin | CEO and … | Aug 13 '26 | Sale | 32199927,0 |
| Duato Joaquin | Officer | Aug 13 '26 | Proposed Sale | 32199927,0 |
| Duato Joaquin | CEO and … | Aug 05 '26 | Sale | 12515010,0 |
| Forminard Elizabeth | EVP, Chief … | Aug 06 '26 | Option Exercise | 1232847,0 |
| Forminard Elizabeth | EVP, Chief … | Aug 06 '26 | Sale | 4090960,0 |
| Forminard Elizabeth | Officer | Aug 06 '26 | Proposed Sale | 4090957,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر JNJ والمشاعر والاتجاه
This healthcare giant is on a serious run, but with the stock trading at a peak, investors must decide if …
Investing.com -- JPMorgan reiterated a favorable view on the healthcare sector in a note Tuesday, calling the risk/reward attractive after …
Specialist funds returned nearly 40% as AI drug discovery and deal activity attracted additional capital.
The company that used to reassure you with its sheer breadth now leads with a push to dominate oncology, and …
STORY: U.S. stocks ended mixed on Friday, with the Dow gaining just under half a percent, the S&P 500 virtually …
Investors didn't seem to think so after the company published it.
تحليل متعدد المزودين بالذكاء الاصطناعي